messenger RNA (mRNA)

Biotechnology company, BioNTech, has entered into a multi-year research and development (R&D) collaboration with Pfizer for the development of mRNA-based vaccines for the prevention of influenza (flu). Read more


Evonik outlines new opportunities for drug delivery via advanced parenteral formulations, the positives and the pitfalls. Read more


A clinically applicable mRNA cancer immunotherapy vaccine has been developed by BioNTech, a biotechnology company developing individualised cancer immunotherapies and TRON, the translational oncology department at the Johannes Gutenberg University Read more


Sanofi and BioNTech have entered into a research collaboration and license agreement to develop up to five cancer immunotherapies Read more